NEWARK, Del — According to Future Market Insights, the global zoonotic antivirals market is valued at USD 2.5 billion in 2026 and is projected to reach USD 6.6 billion by 2036, expanding at a 10.2% CAGR from 2026 to 2036. Market demand is being shaped by outbreak preparedness, surveillance at the human-animal interface, strategic stockpiling, and the need for antiviral agents that can be...